Trials

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid

DUBLIN, IRELAND: Will Represent Sixth U.S. Patent to Be Listed in the Orange Book for RAVICTI ...

Horizon Pharma plc Raises Full-Year 2016 Net Sales and Adjusted EBITDA Guidance Based on Expected Close of the Crealta Holdings LLC Acquisition

DUBLIN, IRELAND: Raises Full-Year 2016 Net Sales Guidance to $1.025 to $1.050 Billion; Raises Full-Year 2016 Adjusted EBITDA Guidance to $505 Million to $520 Million; Hart-Scott-Rodino Waiting Period Expired Effective ...

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/13/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and comm ...

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2015 Financial Results

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/10/15 -- (NASDAQ: TTNP) today announced that it will host a live conference call at 1:05 p.m. PT / 4:05 p.m. ET on Monday, Nov. 16, 2015 to discuss the ...

Cromos(TM) Pharma announces the launch of "No Patients = No Payments" initiative

PORTLAND, OR: PORTLAND, OR -- (Marketwired) -- 10/28/15 -- , an international full-service CRO is strengthening its message of being able to deliver unparalleled patient recruitment with a disruptive initiative.T ...

Medifocus Inc. Presenting Papers at Biotechnology and Information Technology's 5th Annual Symposium in Beijing, October 20-22, 2015

COLUMBIA, MD and TORONTO, ON: Papers to Discuss Heat-Activated and Tumor Targeted Immunotherapy and Gene Therapy; Medifocus Inc.'s CEO Dr. Augustine Cheung Chairing Anticancer Targeted Drug Delivery Session ...

Horizon Pharma plc Files Definitive Proxy Statement for Extraordinary General Meeting of Horizon Pharma Shareholders

DUBLIN, IRELAND: Principal Purpose of the Meeting Is to Take Actions Relating to Horizon Pharma's Proposed Acquisition of Depomed, Inc. ...

Horizon Pharma plc Files Preliminary Proxy Materials for Special Meetings

DUBLIN, IRELAND: Intends to Solicit Proxies From Depomed Inc. Shareholders for the Removal and Replacement of Depomed's Current Board and the Repeal of a Series of Recent Amendments to Depomed's Bylaws ...

Titan Pharmaceuticals Provides Opinion of Counsel Covering Issuance and Resale of Shares Underlying Public Warrants

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/07/15 -- (OTCQB: TTNPD), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing ...

Theravance Biopharma Announces FDA Acceptance of sNDA to Expand VIBATIV(R) (telavancin) Labeling

DUBLIN, IRELAND: Company Seeks Expanded Label Supporting VIBATIV Use Against Concurrent Bacteremia in Cases of Complicated Skin and Skin Structure Infections (cSSSI) or Hospital-Acquired and Ventilator-Associated Bact ...